Principal/Consultant, Medical Innovation and Insights, and Fmr. VP, Global Medical Excellence, AstraZeneca
Mary Alice Dwyer, PharmD, is an experienced Medical Affairs leader with expertise and proven track record in creating transformational change initiatives, building and leading effective Medical Affairs teams, and implementing patient-centric practices. An enterprise-wide and global leader whose achievements include developing and leading a Medical Excellence function that elevated Medical Affairs deliverables through global, regional, and local medical partnerships while ensuring strong governance processes. Mary Alice has led patient centricity practices, which have established patient networks that provide insight and impact drug development.
Most recently, Mary Alice was Vice President of Global Medical Excellence (GME) at AstraZeneca. She led the GME organization which included Global Publications, Global MSL Excellence, Global Nominated Signatory, the Medical Academy, Medical Resources, and Patient Centricity (PaCe). In this role, she led the partnership between GME and Medical in the regions and countries to build and sustain medical capabilities, skills and knowledge. Mary Alice first joined AstraZeneca in 2004 as the Executive Director of Scientific Affairs and was subsequently promoted to Vice President of Medical Affairs in the US. She has also led scientific and medical teams at Takeda, Pharmacia, and Searle. She previously worked in clinical drug development at Hoffmann-LaRoche and Glaxo.
Mary Alice is currently the Principal/Consultant with Medical Innovation and Insights, providing Medical Affairs consulting services.